* Cardlytics Inc CDLX.OQ reported a quarterly adjusted
loss
of 15 cents per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of -24 cents. The mean expectation of five analysts for the
quarter was for a loss of 13 cents per share. Wall Street
expected results to range from -25 cents to -1 cents per share.
* Revenue fell 9.2% to $69.64 million from a year ago;
analysts
expected $75.37 million.
* Cardlytics Inc's reported EPS for the quarter was a loss
of 9
cents.
* The company reported a quarterly loss of $4.26 million.
* Cardlytics Inc shares had fallen by 10.8% this quarter and
lost 20.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 7.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the software peer
group
is also "buy"
Wall Street's median 12-month price target for Cardlytics Inc is
$14.00
This summary was machine generated from LSEG data August 8 at
03:34 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.13 -0.15 Missed
Mar. 31 2024 -0.11 -0.09 Beat
Dec. 31 2023 0.12 0.14 Beat
Sep. 30 2023 -0.01 0.01 Beat